Rural Pharmacy and Prescription Drugs – Resources
Selected recent or important resources focusing on Rural Pharmacy and Prescription Drugs.
PharmD Concentration Helps Pharmacy Students Prepare for a Career in Rural America
Features the Rural Pharmacy Practice program, a concentration for PharmD students at the University of Wisconsin–Madison School of Pharmacy who are interested in working in rural communities. Describes how the program was created. Discusses the experiences students have, including conducting community needs assessments and related population health projects.
Author(s): Allee Mead
Citation: Rural Monitor
Date: 10/2020
Sponsoring organization: Rural Health Information Hub
view details
Features the Rural Pharmacy Practice program, a concentration for PharmD students at the University of Wisconsin–Madison School of Pharmacy who are interested in working in rural communities. Describes how the program was created. Discusses the experiences students have, including conducting community needs assessments and related population health projects.
Author(s): Allee Mead
Citation: Rural Monitor
Date: 10/2020
Sponsoring organization: Rural Health Information Hub
view details
Telepharmacy and Quality of Medication Use in Rural Areas, 2013–2019
Uses dispensing records from traditional pharmacies and telepharmacies in the Midwest to compare patients' adherence to and inappropriate use of prescription medications between 2013 and 2019. Includes data and statistics on medication adherence and use, with information broken down by patient characteristics, such as age, rurality, payer, risk, and more.
Author(s): Shweta Pathak, Mitchell Haynes, Dima Qato, Benjamin Urick
Citation: Preventing Chronic Disease, 17
Date: 09/2020
view details
Uses dispensing records from traditional pharmacies and telepharmacies in the Midwest to compare patients' adherence to and inappropriate use of prescription medications between 2013 and 2019. Includes data and statistics on medication adherence and use, with information broken down by patient characteristics, such as age, rurality, payer, risk, and more.
Author(s): Shweta Pathak, Mitchell Haynes, Dima Qato, Benjamin Urick
Citation: Preventing Chronic Disease, 17
Date: 09/2020
view details
Buyback Program of Unused Prescription Opioids in US Rural Communities, 2017–2018
Describes a buyback intervention that was designed to encourage rural, ambulatory surgery patients to return unused prescription opioids to a U.S. Department of Veterans Affairs (VA) hospital. Provides data on patient characteristics as well as percent of opioids prescribed and returned during 2017 and 2018. Includes implications for public health.
Author(s): Jean Liu, Julie Franklin, Frank Gesek, Joseph Anderson
Citation: American Journal of Public Health, 110(9), 1318-1324
Date: 09/2020
view details
Describes a buyback intervention that was designed to encourage rural, ambulatory surgery patients to return unused prescription opioids to a U.S. Department of Veterans Affairs (VA) hospital. Provides data on patient characteristics as well as percent of opioids prescribed and returned during 2017 and 2018. Includes implications for public health.
Author(s): Jean Liu, Julie Franklin, Frank Gesek, Joseph Anderson
Citation: American Journal of Public Health, 110(9), 1318-1324
Date: 09/2020
view details
Telepharmacy Rules and Statutes: A 3-Year Update for all 50 States
Surveys the legislative and administrative activity authorizing community-based telepharmacy. Includes a table identifying states that have permitted telepharmacy services through legislation, regulation, or waiver or pilot programs, and states with limitations, prohibitions, or no guidance on these services. Provides an overview of state rules and regulations that limit aspects of telepharmacy implementation. Explores areas for further research and evaluation, including the relationship between telepharmacy and rural pharmacy closures.
Author(s): Jason Semprini, Fred Ullrich, Keith J. Mueller
Date: 07/2020
Sponsoring organization: RUPRI Center for Rural Health Policy Analysis
view details
Surveys the legislative and administrative activity authorizing community-based telepharmacy. Includes a table identifying states that have permitted telepharmacy services through legislation, regulation, or waiver or pilot programs, and states with limitations, prohibitions, or no guidance on these services. Provides an overview of state rules and regulations that limit aspects of telepharmacy implementation. Explores areas for further research and evaluation, including the relationship between telepharmacy and rural pharmacy closures.
Author(s): Jason Semprini, Fred Ullrich, Keith J. Mueller
Date: 07/2020
Sponsoring organization: RUPRI Center for Rural Health Policy Analysis
view details
Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine
Describes the role of rural pharmacists in promoting and administering the human papillomavirus (HPV) vaccine using information gathered from interviews of 11 pharmacists at independently owned pharmacies in Iowa. Identifies factors facilitating the administration and accessibility of the vaccine and reports on personal barriers regarding safety, lack of information, and staff capacity.
Author(s): Grace Ryan, Eliza Daly, Natoshia Askelson, et al.
Citation: Preventing Chronic Disease, 17
Date: 03/2020
view details
Describes the role of rural pharmacists in promoting and administering the human papillomavirus (HPV) vaccine using information gathered from interviews of 11 pharmacists at independently owned pharmacies in Iowa. Identifies factors facilitating the administration and accessibility of the vaccine and reports on personal barriers regarding safety, lack of information, and staff capacity.
Author(s): Grace Ryan, Eliza Daly, Natoshia Askelson, et al.
Citation: Preventing Chronic Disease, 17
Date: 03/2020
view details
340B Drug Discount Program: Increased Oversight Needed to Ensure Nongovernmental Hospitals Meet Eligibility Requirements
Provides an overview of the Government Accountability Office's (GAO) review of 258 nongovernmental hospitals that participate in the 340B Drug Pricing Program and their contracts with state and local governments. Evaluates the contracts to determine if they meet the eligibility requirement to serve low-income individuals. Outlines weaknesses in the Health Resources and Services Administration's review of the hospital contracts and offers six recommendations to improve the contract review process.
Additional links: Full Report
Date: 12/2019
Sponsoring organization: Government Accountability Office
view details
Provides an overview of the Government Accountability Office's (GAO) review of 258 nongovernmental hospitals that participate in the 340B Drug Pricing Program and their contracts with state and local governments. Evaluates the contracts to determine if they meet the eligibility requirement to serve low-income individuals. Outlines weaknesses in the Health Resources and Services Administration's review of the hospital contracts and offers six recommendations to improve the contract review process.
Additional links: Full Report
Date: 12/2019
Sponsoring organization: Government Accountability Office
view details
Electronic Prescribing of Controlled Substances among Office-Based Physicians, 2017
Examines rates of electronic prescribing of controlled substances (EPCS), with information by type of physician practice, including rural or urban location, practice size, practice ownership, physician specialty, and technology available. EPCS is mandated for Medicare Part D providers by 2021, through the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.
Author(s): Sonal Parasrampuria, Martin Blanco, Wesley Barker
Date: 09/2019
Sponsoring organization: Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology
view details
Examines rates of electronic prescribing of controlled substances (EPCS), with information by type of physician practice, including rural or urban location, practice size, practice ownership, physician specialty, and technology available. EPCS is mandated for Medicare Part D providers by 2021, through the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.
Author(s): Sonal Parasrampuria, Martin Blanco, Wesley Barker
Date: 09/2019
Sponsoring organization: Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information Technology
view details
Opioid Prescribing Rates in Nonmetropolitan and Metropolitan Counties Among Primary Care Providers Using an Electronic Health Record System — United States, 2014–2017
Examines opioid prescribing rates among primary care providers for six urban-rural classification categories of counties, before and after the March 2016 release of CDC's Guideline for Prescribing Opioids for Chronic Pain.
Author(s): Macarena C. García, Charles M. Heilig, Scott H. Lee, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 68(2), 25-30
Date: 01/2019
Sponsoring organization: Centers for Disease Control and Prevention
view details
Examines opioid prescribing rates among primary care providers for six urban-rural classification categories of counties, before and after the March 2016 release of CDC's Guideline for Prescribing Opioids for Chronic Pain.
Author(s): Macarena C. García, Charles M. Heilig, Scott H. Lee, et al.
Citation: MMWR (Morbidity and Mortality Weekly Report), 68(2), 25-30
Date: 01/2019
Sponsoring organization: Centers for Disease Control and Prevention
view details
Drug Discount Program: Characteristics of Hospitals Participating and Not Participating in the 340B Program
Analyzes 2016 cost report data to describe and compare characteristics of 340B participating and non-participating hospitals, specifically examining three hospital types: Critical Access Hospitals (CAHs), Sole Community Hospitals (SCHs), and general acute care hospitals. Discusses trends related to decreased charity care and an increase in Medicaid expansion on 340B hospital participation.
Additional links: Full Report
Date: 07/2018
Sponsoring organization: Government Accountability Office
view details
Analyzes 2016 cost report data to describe and compare characteristics of 340B participating and non-participating hospitals, specifically examining three hospital types: Critical Access Hospitals (CAHs), Sole Community Hospitals (SCHs), and general acute care hospitals. Discusses trends related to decreased charity care and an increase in Medicaid expansion on 340B hospital participation.
Additional links: Full Report
Date: 07/2018
Sponsoring organization: Government Accountability Office
view details
Drug Discount Program: Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement
Focuses on the 340B Drug Pricing Program, which allows certain facilities such as Disproportionate Share Hospitals (DSHs), Federally Qualified Health Centers (FQHCs), and Critical Access Hospitals (CAHs) to purchase prescription and non-prescription medications at reduced cost. Describes financial arrangements participating facilities have with contract pharmacies, the extent to which they provide discounts on 340B drugs dispensed by contract pharmacies to low-income, uninsured patients, and examines the Health Resources and Services Administration's efforts to ensure compliance with 340B Program requirements at contract pharmacies.
Additional links: Full Report
Date: 06/2018
Sponsoring organization: Government Accountability Office
view details
Focuses on the 340B Drug Pricing Program, which allows certain facilities such as Disproportionate Share Hospitals (DSHs), Federally Qualified Health Centers (FQHCs), and Critical Access Hospitals (CAHs) to purchase prescription and non-prescription medications at reduced cost. Describes financial arrangements participating facilities have with contract pharmacies, the extent to which they provide discounts on 340B drugs dispensed by contract pharmacies to low-income, uninsured patients, and examines the Health Resources and Services Administration's efforts to ensure compliance with 340B Program requirements at contract pharmacies.
Additional links: Full Report
Date: 06/2018
Sponsoring organization: Government Accountability Office
view details
Additional resources are available related to this guide. See the full list of resources by topic for:
Last Updated: 7/10/2025